+467.0%
MRNA vs NTAP
+63.1%
+403.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NTAP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +8.5% | -3.2% | +7.8% |
| 7D | -1.1% | +7.4% | -8.5% | +0.9% |
| 30D | +126.1% | -1.4% | +127.5% | +125.3% |
| 3M | +190.0% | +24.6% | +165.5% | +176.4% |
| 6M | +157.2% | +105.9% | +51.3% | +106.4% |
| YTD | +388.2% | +88.5% | +299.7% | +299.8% |
| 1Y | +467.0% | +62.1% | +404.9% | +409.9% |
| All | +467.0% | +63.1% | +403.9% | +409.9% |
Cumulative growth
Daily Returns
Daily percentage return beside NTAP.
Daily Out/Under-Performance
Portfolio return minus NTAP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTAP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NTAP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling